Last reviewed · How we verify

NCT06308042

Remote Evaluation in Patients With Multiple Sclerosis

Status unknown Last updated 13 March 2024
What this trial tests

trial testing 30 second sit and stand test in Multiple Sclerosis in 10 participants. Status unknown.

Timeline
11 March 2024
Primary endpoint
24 June 2024
29 June 2024

Quick facts

Lead sponsorInonu University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10
Start date11 March 2024
Primary completion24 June 2024
Estimated completion29 June 2024

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to demonstrate the remote reliability of the 30-second sit-to-stand test in patients with multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06308042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing